| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-08-29 13:28:09 UTC |
|---|
| Update Date | 2021-09-26 22:48:55 UTC |
|---|
| HMDB ID | HMDB0242299 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
|---|
| Description | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Based on a literature review very few articles have been published on (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one. This compound has been identified in human blood as reported by (PMID: 31557052 ). (17r)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(O)CC=C InChI=1S/C21H26O2/c1-3-10-21(23)12-9-19-18-6-4-14-13-15(22)5-7-16(14)17(18)8-11-20(19,21)2/h3,8,11,13,18-19,23H,1,4-7,9-10,12H2,2H3 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C21H26O2 |
|---|
| Average Molecular Weight | 310.437 |
|---|
| Monoisotopic Molecular Weight | 310.193280077 |
|---|
| IUPAC Name | 14-hydroxy-15-methyl-14-(prop-2-en-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6,16-trien-5-one |
|---|
| Traditional Name | 14-hydroxy-15-methyl-14-(prop-2-en-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6,16-trien-5-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(O)CC=C |
|---|
| InChI Identifier | InChI=1S/C21H26O2/c1-3-10-21(23)12-9-19-18-6-4-14-13-15(22)5-7-16(14)17(18)8-11-20(19,21)2/h3,8,11,13,18-19,23H,1,4-7,9-10,12H2,2H3 |
|---|
| InChI Key | VWAUPFMBXBWEQY-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Estrane steroids |
|---|
| Direct Parent | Estrogens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Estrogen-skeleton
- 3-oxosteroid
- Hydroxysteroid
- 17-hydroxysteroid
- Oxosteroid
- Cyclohexenone
- Cyclic alcohol
- Tertiary alcohol
- Cyclic ketone
- Ketone
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Alcohol
- Organooxygen compound
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 6.78 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 17.9847 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.19 minutes | 32390414 |
Predicted Kovats Retention IndicesDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #1 | C=CCC1(O[Si](C)(C)C)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C | 2922.9 | Semi standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #1 | C=CCC1(O[Si](C)(C)C)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C | 2853.4 | Standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #1 | C=CCC1(O[Si](C)(C)C)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C | 3247.8 | Standard polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #2 | C=CCC1(O)CCC2C3CCC4=CC(O[Si](C)(C)C)=CCC4=C3C=CC21C | 2899.4 | Semi standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #2 | C=CCC1(O)CCC2C3CCC4=CC(O[Si](C)(C)C)=CCC4=C3C=CC21C | 2817.9 | Standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #2 | C=CCC1(O)CCC2C3CCC4=CC(O[Si](C)(C)C)=CCC4=C3C=CC21C | 3347.8 | Standard polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,2TMS,isomer #1 | C=CCC1(O[Si](C)(C)C)CCC2C3CCC4=CC(O[Si](C)(C)C)=CCC4=C3C=CC21C | 2955.3 | Semi standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,2TMS,isomer #1 | C=CCC1(O[Si](C)(C)C)CCC2C3CCC4=CC(O[Si](C)(C)C)=CCC4=C3C=CC21C | 2910.5 | Standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,2TMS,isomer #1 | C=CCC1(O[Si](C)(C)C)CCC2C3CCC4=CC(O[Si](C)(C)C)=CCC4=C3C=CC21C | 3304.3 | Standard polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #1 | C=CCC1(O[Si](C)(C)C(C)(C)C)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C | 3178.3 | Semi standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #1 | C=CCC1(O[Si](C)(C)C(C)(C)C)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C | 3139.6 | Standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #1 | C=CCC1(O[Si](C)(C)C(C)(C)C)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C | 3387.7 | Standard polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #2 | C=CCC1(O)CCC2C3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CCC4=C3C=CC21C | 3147.8 | Semi standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #2 | C=CCC1(O)CCC2C3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CCC4=C3C=CC21C | 3079.7 | Standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #2 | C=CCC1(O)CCC2C3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CCC4=C3C=CC21C | 3509.6 | Standard polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,2TBDMS,isomer #1 | C=CCC1(O[Si](C)(C)C(C)(C)C)CCC2C3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CCC4=C3C=CC21C | 3451.5 | Semi standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,2TBDMS,isomer #1 | C=CCC1(O[Si](C)(C)C(C)(C)C)CCC2C3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CCC4=C3C=CC21C | 3434.2 | Standard non polar | 33892256 | | (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one,2TBDMS,isomer #1 | C=CCC1(O[Si](C)(C)C(C)(C)C)CCC2C3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CCC4=C3C=CC21C | 3506.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one GC-MS (Non-derivatized) - 70eV, Positive | splash10-007p-1190000000-0726e0cfff124f4e42dc | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 10V, Positive-QTOF | splash10-03di-0039000000-a14037a945882f81ea8f | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 20V, Positive-QTOF | splash10-01vk-0591000000-d62aca36453e3636f30c | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 40V, Positive-QTOF | splash10-0arr-6490000000-41dc5fa937d027077d04 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 10V, Negative-QTOF | splash10-0a4i-0009000000-d834b990dbff0e00d266 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 20V, Negative-QTOF | splash10-0a4i-0019000000-67613c34118bd7138c57 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (17R)-17-Hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 40V, Negative-QTOF | splash10-0zfu-0091000000-d31a3f4fe14a3725a1fd | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|